Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$6,967,489
+$1,741,356 QoQ
Shares Held
5,809
+2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.55%
of 13F equity value
Holder Rank
#1,477
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BankPlus Trust Department holds $22,905,605 across 10 Drug Manufacturers - General names. LLY ranks #1 (30.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,809 | $6,967,489 | |
| 2 | ABBV |
AbbVie Inc.
|
26,903 | $6,769,870 | |
| 3 | AMGN |
Amgen Inc
|
12,589 | $4,558,728 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
32,563 | $1,876,280 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,294 | $1,322,779 | |
| 6 | JNJ |
Johnson & Johnson
|
2,984 | $757,846 | |
| 7 | PFE |
Pfizer Inc
|
12,552 | $302,252 | |
| 8 | SNY |
Sanofi
|
6,400 | $273,024 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,967,489 | 5,809 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,226,133 | 5,682 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,712,979 | 7,177 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $5,624,073 | 7,371 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $5,904,160 | 7,574 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $6,099,345 | 7,385 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $5,883,412 | 7,621 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||